0,852  0,003  Sensitization
0,795  0,017  Apoptosis agonist
0,766  0,020  Antiinflammatory
0,737  0,013  Teratogen
0,733  0,017  Transcription factor NF kappa B inhibitor
0,721  0,013  Embryotoxic
0,708  0,011  Carcinogenic
0,699  0,018  CYP3A4 substrate
0,696  0,019  Antineoplastic (lung cancer)
0,678  0,004  UGT1A4 substrate
0,660  0,013  Respiratory analeptic
0,645  0,008  AR expression inhibitor
0,651  0,018  TNF expression inhibitor
0,607  0,014  Bone diseases treatment
0,598  0,006  Antineoplastic (endocrine cancer)
0,586  0,004  Contraceptive
0,593  0,012  Antipruritic, allergic
0,605  0,034  Antineoplastic (breast cancer)
0,549  0,018  Analeptic
0,543  0,015  Antiosteoporotic
0,523  0,003  UGT2B9 substrate
0,527  0,007  UGT2B4 substrate
0,550  0,031  Antileukemic
0,533  0,015  NOS2 expression inhibitor
0,527  0,014  Nitric oxide antagonist
0,531  0,018  Antineoplastic (pancreatic cancer)
0,512  0,007  Hair growth stimulant
0,515  0,011  UDP-glucuronosyltransferase substrate
0,507  0,004  5 Hydroxytryptamine uptake stimulant
0,505  0,005  Abortion inducer
0,503  0,006  Interferon gamma antagonist
0,522  0,027  Immunosuppressant
0,506  0,020  Cytostatic
0,509  0,023  Cytotoxic
0,483  0,005  UGT2B7 substrate
0,489  0,020  Chemopreventive
0,475  0,006  Antiacne
0,490  0,021  NOS3 expression inhibitor
0,493  0,028  Antineoplastic (ovarian cancer)
0,497  0,037  CYP2C9 substrate
0,466  0,007  Prostate disorders treatment
0,459  0,004  Antipruritic, non-allergic
0,463  0,008  Prostatic (benign) hyperplasia treatment
0,459  0,005  Lipocortins synthesis antagonist
0,477  0,024  Antipsoriatic
0,467  0,018  Antiparasitic
0,456  0,011  Antineoplastic (sarcoma)
0,453  0,009  Carcinogenic, group 3
0,461  0,022  Proliferative diseases treatment
0,449  0,034  Antihypercholesterolemic
0,455  0,040  Prostate cancer treatment
0,481  0,068  Caspase 9 stimulant
0,426  0,014  Anesthetic general
0,437  0,025  Cardiovascular analeptic
0,440  0,033  Antineoplastic (melanoma)
0,435  0,029  Chemoprotective
0,437  0,036  CYP2C19 substrate
0,428  0,032  Antineoplastic (cervical cancer)
0,391  0,009  UGT2B15 substrate
0,424  0,045  Cholesterol antagonist
0,395  0,017  Antihelmintic
0,394  0,019  Sodium/bile acid cotransporter inhibitor
0,407  0,037  ICAM1 expression inhibitor
0,374  0,020  UGT1A1 substrate
0,384  0,032  Mutagenic
0,373  0,030  Antidiabetic symptomatic
0,361  0,019  Skin irritative effect
0,353  0,016  Melanin inhibitor
0,365  0,031  Antineoplastic (osteosarcoma)
0,343  0,015  Pneumotoxic
0,343  0,019  Antihypotensive
0,338  0,017  Anesthetic
0,341  0,036  Antineoplastic (liver cancer)
0,356  0,057  Caspase 3 stimulant
0,302  0,005  Estrogen agonist
0,304  0,010  Antifungal enhancer
0,330  0,039  Angiogenesis stimulant
0,351  0,065  Antineoplastic (colorectal cancer)
0,346  0,062  Antifungal
0,297  0,017  Antiviral (Influenza A)
0,331  0,052  Antioxidant
0,379  0,103  Cyclophilin D inhibitor
0,379  0,103  Antidiabetic
0,303  0,029  Hepatoprotectant
0,304  0,029  Antiviral (Influenza)
0,291  0,018  Protein kinase stimulant
0,313  0,039  DNA synthesis inhibitor
0,278  0,007  Contraceptive male
0,276  0,008  Androgen antagonist
0,282  0,018  Interleukin 6 antagonist
0,329  0,068  Hepatic disorders treatment
0,327  0,067  Antineoplastic (colon cancer)
0,262  0,003  Glucocorticoid antagonist
0,261  0,004  Arachidonic acid antagonist
0,260  0,004  Progesterone antagonist
0,316  0,063  CTGF expression inhibitor
0,312  0,060  Hypoxia-inducible factor 1 alpha inhibitor
0,253  0,004  5-Alpha-reductase inhibitor
0,258  0,011  UGT2B10 substrate
0,254  0,008  Microtubule formation inhibitor
0,289  0,047  UGT1A6 substrate
0,316  0,077  Calcium channel activator
0,232  0,005  Vanilloid agonist
0,238  0,011  SULT1A1 substrate
0,232  0,007  Antineoplastic alkaloid
0,223  0,003  UGT2B11 substrate
0,226  0,010  Contraceptive female
0,229  0,015  Farnesoid X receptor antagonist
0,278  0,064  Antineoplastic (glioma)
0,329  0,115  Antibacterial
0,303  0,091  Angiogenesis inhibitor
0,212  0,003  Anabolic
0,220  0,014  Alcohol dehydrogenase substrate
0,219  0,015  Sulfotransferase substrate
0,220  0,016  Endometrios treatment
0,250  0,049  Sedative
0,208  0,008  Aromatase inhibitor
0,237  0,040  Eye irritation, high
0,200  0,004  Estrogen receptor alpha agonist
0,237  0,042  Antimutagenic
0,266  0,075  UGT1A9 substrate
0,267  0,076  Aldehyde oxidase inhibitor
0,305  0,121  CYP2C19 inhibitor
0,207  0,025  Cholesterol synthesis inhibitor
0,186  0,005  Estrogen receptor beta agonist
0,184  0,004  Aldosterone antagonist
0,200  0,021  Antineoplastic antibiotic
0,187  0,009  Postmenopausal disorders treatment
0,264  0,088  Antineoplastic (multiple myeloma)
0,182  0,015  Estrogen antagonist
0,232  0,066  Antiviral (HIV)
0,263  0,099  CYP2D6 substrate
0,268  0,110  Apoptosis antagonist
0,223  0,065  VCAM1 expression inhibitor
0,222  0,066  Antialcoholic
0,210  0,058  P-glycoprotein inhibitor
0,182  0,029  Antieczematic
0,164  0,012  SULT1E1 substrate
0,178  0,028  Adenylate cyclase stimulant
0,258  0,109  Immunomodulator
0,263  0,115  FMO1 substrate
0,173  0,027  Growth stimulant
0,206  0,063  CYP2B6 inhibitor
0,178  0,036  DNA polymerase I inhibitor
0,210  0,068  Neurotrophic factor enhancer
0,149  0,007  Androgen agonist
0,147  0,006  Hypercalcemia treatment
0,191  0,051  Antiviral (Herpes)
0,190  0,052  Antirickettsial
0,163  0,027  Choleretic
0,151  0,015  Estrogen receptor beta antagonist
0,145  0,012  Estrogen receptor alpha antagonist
0,160  0,029  Vanilloid 1 agonist
0,151  0,020  Actinic keratosis treatment
0,135  0,007  Ca(v)3.1 blocker
0,135  0,010  Na+ K+ transporting ATPase inhibitor
0,182  0,066  Succinate dehydrogenase inhibitor
0,134  0,020  Inducible nitric-oxide synthase inhibitor
0,177  0,065  UGT1A3 substrate
0,162  0,050  Movement disorders treatment
0,201  0,092  Antineoplastic (lymphoma)
0,113  0,004  Postcoital contraceptive
0,148  0,047  Ca2+-transporting ATPase inhibitor
0,128  0,030  Posttraumatic stress disorder treatment
0,134  0,037  UGT2B1 substrate
0,203  0,107  Tumour necrosis factor alpha release inhibitor
0,169  0,075  Toxic, respiratory center
0,099  0,006  RNA-directed RNA polymerase stimulant
0,156  0,063  Genotoxic
0,097  0,006  Lipocortins synthesis agonist
0,095  0,004  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,156  0,067  NOS3 expression enhancer
0,143  0,054  Antihemorrhagic
0,211  0,122  Cardioprotectant
0,183  0,095  Antineoplastic (glioblastoma multiforme)
0,110  0,025  Glycine receptor antagonist
0,102  0,017  Anticholelithogenic
0,159  0,077  Antihelmintic (Nematodes)
0,128  0,046  Expectorant
0,091  0,010  Potassium channel Kv1.3 blocker
0,122  0,044  Electron transport complex I inhibitor
0,101  0,024  T cell inhibitor
0,109  0,032  Transcription factor NF kappa B stimulant
0,197  0,122  Spasmolytic
0,079  0,004  Progesterone agonist
0,087  0,012  Estradiol 17 beta-dehydrogenase inhibitor
0,081  0,006  Pregnane X receptor antagonist
0,146  0,071  Antineoplastic (carcinoma)
0,132  0,058  Antiviral (Hepatitis B)
0,077  0,005  Parathyroid hormone antagonist
0,082  0,011  Mineralocorticoid receptor antagonist
0,189  0,119  Antineoplastic (renal cancer)
0,130  0,060  Coagulant
0,140  0,071  Antineoplastic (squamous cell carcinoma)
0,086  0,018  SULT2A1 substrate
0,094  0,027  Cushing's syndrome treatment
0,125  0,058  Menstruation disorders treatment
0,174  0,108  Antiulcerative
0,145  0,081  Acute respiratory distress syndrome (ARDS) treatment
0,139  0,076  Lipid peroxidase inhibitor
0,120  0,058  TRPA1 agonist
0,224  0,163  GST A substrate
0,175  0,115  Antineoplastic enhancer
0,120  0,061  Monophenol monooxygenase inhibitor
0,103  0,046  ABCA1 expression enhancer
0,093  0,038  Antibiotic
0,128  0,074  Skin whitener
0,059  0,004  Vitamin D receptor antagonist
0,119  0,064  Protein-tyrosine phosphatase 1B inhibitor
0,089  0,035  CDC25A inhibitor
0,057  0,004  Glucocorticoid agonist
0,085  0,032  Premenstrual syndrome treatment
0,113  0,061  Mucolytic
0,112  0,062  GABA C receptor antagonist
0,072  0,023  Heme oxygenase stimulant
0,061  0,014  Microtubule stabilization
0,143  0,097  Muscle relaxant
0,108  0,062  Carcinogenic, group 2B
0,052  0,007  Tubulin agonist
0,178  0,134  Immunostimulant
0,085  0,043  Keratolytic
0,055  0,012  Hypogonadism treatment
0,127  0,085  Neurotrophic factor
0,114  0,073  Topoisomerase II inhibitor
0,082  0,042  SULT1A2 substrate
0,046  0,007  5-Alpha-reductase 1 inhibitor
0,122  0,084  Bone formation stimulant
0,050  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,088  0,050  3C-Like protease (SARS coronavirus) inhibitor
0,210  0,173  Interleukin 2 agonist
0,086  0,051  Antiprotozoal activity enhancer
0,111  0,076  Autism spectrum disorders treatment
0,037  0,004  Corticosteroid-like
0,147  0,116  LDLR expression enhancer
0,208  0,177  GST M1-1 substrate
0,171  0,140  Vascular (periferal) disease treatment
0,088  0,059  Ornithine decarboxylase inhibitor
0,193  0,164  CYP1A2 substrate
0,184  0,156  Antiepileptic
0,156  0,130  Antiparkinsonian, rigidity relieving
0,124  0,100  SULT1A3 substrate
0,032  0,008  Vanilloid 2 agonist
0,032  0,009  CYP24 inhibitor
0,086  0,063  Tocolytic
0,041  0,019  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,123  0,101  Diuretic
0,158  0,136  Antiprotozoal (Leishmania)
0,071  0,052  Glycine receptor agonist
0,047  0,030  Adenylate cyclase 1 inhibitor
0,025  0,007  Progesterone receptor B antagonist
0,027  0,010  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,118  0,101  Psychosexual dysfunction treatment
0,026  0,010  5-Alpha-reductase 2 inhibitor
0,041  0,025  GABA uptake inhibitor
0,052  0,038  Protein 50S ribosomal subunit inhibitor
0,077  0,065  Antispirochetal
0,023  0,014  Estrone sulfatase inhibitor
0,014  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,124  0,118  Pregnane X receptor agonist
0,099  0,094  Aldehyde dehydrogenase substrate
0,008  0,003  Transcortin receptor antagonist
0,070  0,067  Narcotic antagonist
0,031  0,028  Retinoid X receptor agonist
0,047  0,044  Anesthetic inhalation
0,026  0,023  Retinoid X gamma receptor antagonist
0,016  0,014  Telomerase stimulant
0,004  0,003  Vitamin D-like
0,015  0,015  Vitamin D receptor agonist

